Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BKGFY The Berkeley Group	$11.41 +2.0%	$10.23	$8.48 ▼ $15.11	$5.65B	1.32	265,966 shs	168,457 shs
DSRLF DiaSorin	$104.69	$108.77	$100.01 ▼ $109.60	$5.73B	0.01	100 shs	N/A
KCDMY Kimberly-Clark de México, S. A. B. de C. V.	$9.20 -1.1%	$8.41	$6.50 ▼ $11.27	$5.66B	0.77	58,541 shs	17,547 shs
PHMMF Pharma Mar	$80.91	$90.94	$26.85 ▼ $105.60	$1.46B	0.25	1,280 shs	N/A

Elon Musk's Next Move

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BKGFY The Berkeley Group	-2.61%	-3.03%	+10.25%	+17.05%	-16.18%
DSRLF DiaSorin	0.00%	-3.96%	+4.68%	+2.00%	-3.95%
KCDMY Kimberly-Clark de México, S. A. B. de C. V.	+0.76%	+3.51%	+12.45%	+15.38%	-14.01%
PHMMF Pharma Mar	0.00%	-8.25%	-8.25%	-15.53%	+159.74%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
BKGFY The Berkeley Group	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
DSRLF DiaSorin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
KCDMY Kimberly-Clark de México, S. A. B. de C. V.	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
PHMMF Pharma Mar	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BKGFY The Berkeley Group	4.00	Strong Buy	N/A	N/A
DSRLF DiaSorin	2.00	Hold	N/A	N/A
KCDMY Kimberly-Clark de México, S. A. B. de C. V.	0.00	N/A	N/A	N/A
PHMMF Pharma Mar	4.00	Strong Buy	N/A	N/A

Current Analyst Ratings Breakdown

Latest PHMMF, DSRLF, BKGFY, and KCDMY Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target	Details
4/28/2025	BKGFY The Berkeley Group	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold ➝ Strong-Buy

(Data available from 5/15/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BKGFY The Berkeley Group	$3.10B	1.82	$1.16 per share	9.82	$8.76 per share	1.30
DSRLF DiaSorin	$1.24B	4.61	$9.27 per share	11.29	N/A	∞
KCDMY Kimberly-Clark de México, S. A. B. de C. V.	$3.01B	1.88	$1.00 per share	9.24	$0.66 per share	13.94
PHMMF Pharma Mar	$171.15M	8.51	$0.35 per share	231.27	$11.62 per share	6.96

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BKGFY The Berkeley Group	$500.02M	N/A	0.00	14.26	N/A	N/A	N/A	N/A	6/18/2025 (Estimated)
DSRLF DiaSorin	$173.01M	N/A	0.00	∞	N/A	N/A	N/A	N/A	7/28/2025 (Estimated)
KCDMY Kimberly-Clark de México, S. A. B. de C. V.	$429.57M	$0.66	12.96	∞	N/A	14.35%	138.10%	14.43%	7/17/2025 (Estimated)
PHMMF Pharma Mar	$1.23M	N/A	0.00	∞	N/A	N/A	N/A	N/A	7/28/2025 (Estimated)

Latest PHMMF, DSRLF, BKGFY, and KCDMY Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
4/24/2025	Q1 2025	KCDMY Kimberly-Clark de México, S. A. B. de C. V.	$0.1501	$0.15	-$0.0001	$0.15	$14.04 billion	$705.86 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
BKGFY The Berkeley Group	$0.13	1.14%	N/A	N/A	N/A
DSRLF DiaSorin	N/A	N/A	N/A	N/A	N/A
KCDMY Kimberly-Clark de México, S. A. B. de C. V.	$0.11	1.20%	N/A	16.67%	N/A
PHMMF Pharma Mar	N/A	N/A	N/A	N/A	N/A

Latest PHMMF, DSRLF, BKGFY, and KCDMY Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
2/27/2025	BKGFY The Berkeley Group		$0.0833		3/10/2025	3/10/2025	4/14/2025
3/11/2025	KCDMY Kimberly-Clark de México, S. A. B. de C. V.		$0.1246		4/2/2025	4/2/2025	4/10/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BKGFY The Berkeley Group	0.19	3.46	0.66
DSRLF DiaSorin	N/A	3.12	1.89
KCDMY Kimberly-Clark de México, S. A. B. de C. V.	3.27	1.43	1.15
PHMMF Pharma Mar	0.14	2.55	2.01

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BKGFY The Berkeley Group	N/A
DSRLF DiaSorin	N/A
KCDMY Kimberly-Clark de México, S. A. B. de C. V.	N/A
PHMMF Pharma Mar	N/A

Insider Ownership

Company	Insider Ownership
BKGFY The Berkeley Group	N/A
DSRLF DiaSorin	N/A
KCDMY Kimberly-Clark de México, S. A. B. de C. V.	N/A
PHMMF Pharma Mar	1.88%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BKGFY The Berkeley Group	3,030	495.33 million	N/A	Not Optionable
DSRLF DiaSorin	3,186	54.71 million	N/A	Not Optionable
KCDMY Kimberly-Clark de México, S. A. B. de C. V.	9,706	615.03 million	N/A	Not Optionable
PHMMF Pharma Mar	509	18.01 million	N/A	Not Optionable

PHMMF, DSRLF, BKGFY, and KCDMY Headlines

Recent News About These Companies

Positive Phase IIa dose-ranging study for PharmaMar’s SYL1801

May 13 at 6:54 AM | thepharmaletter.com

Pharma Mar, S.A. (OTCMKTS:PHMMF) Short Interest Update

May 5, 2025 | marketbeat.com

Exploring High Growth Tech Stocks in Europe April 2025

April 14, 2025 | finance.yahoo.com

Pharma Mar’s Credit Rating Maintained at ‘BB+’

April 4, 2025 | tipranks.com

Pharma Mar Implements Share Delivery Plan to Boost Employee Engagement

April 2, 2025 | tipranks.com

3 European Growth Stocks With Insider Ownership Seeing Up To 52% Earnings Growth

March 27, 2025 | finance.yahoo.com

Pharma Mar Releases 2024 Director Remuneration Report

February 28, 2025 | tipranks.com

High Insider Ownership Growth Companies To Watch In February 2025

February 21, 2025 | finance.yahoo.com

High Growth Tech Leads These 3 Top Stocks with Potential

February 11, 2025 | finance.yahoo.com

Pharma Mar And 2 Other Stocks That May Be Trading Below Estimated Value

February 4, 2025 | uk.finance.yahoo.com

3 Growth Stocks With Insider Ownership Expecting Up To 71% Earnings Growth

January 23, 2025 | finance.yahoo.com

3 Stocks Estimated To Be Up To 48% Below Intrinsic Value

January 6, 2025 | finance.yahoo.com

Insider-Led Growth Stocks To Watch In December 2024

December 25, 2024 | sg.finance.yahoo.com

Pharma Mar S.A. Reduces Share Capital by Canceling Shares

November 22, 2024 | markets.businessinsider.com

Pharma Mar Achieves Legal Win in Aplidin Case

November 21, 2024 | markets.businessinsider.com

Pharma Mar Hits $10 Million Milestone with Janssen

November 5, 2024 | msn.com

PharmaMar gets $10 million milestone from Janssen for Yondelis

November 5, 2024 | thepharmaletter.com

New miRNA inhibitor could extinguish the 'inflammatory fire' that stroke causes in the brain

October 29, 2024 | msn.com

PHMMF Pharma Mar, S.A.

October 10, 2024 | seekingalpha.com

Chemists develop modular approach for creating important class of pharmaceutical compounds

July 19, 2024 | msn.com

Revolutionizing Pharmaceutical Manufacturing: The Visionary Work of Tejesh Marsale

May 18, 2024 | markets.businessinsider.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

PHMMF, DSRLF, BKGFY, and KCDMY Company Descriptions

The Berkeley Group OTCMKTS:BKGFY

$11.41 +0.22 (+1.97%)

As of 03:59 PM Eastern

The Berkeley Group Holdings plc, together with its subsidiaries, engages in the residential-led and mixed-use property development and ancillary activities in the United Kingdom. The company is involved in land selling activities. It operates under the Berkeley, St Edward, St George, St James, St Joseph, and St William brand names. The Berkeley Group Holdings plc was founded in 1976 and is headquartered in Cobham, the United Kingdom.

DiaSorin OTCMKTS:DSRLF

$104.69 0.00 (0.00%)

As of 05/14/2025

DiaSorin S.p.A. engages in development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, Africa, North America, Central and South America, the Asia Pacific, and China. The company provides various immunodiagnostic LIAISON platforms, including LIAISON XS, LIASON IQ, LIAISON XL, LIAISON XXL, and LIAISON XL LAS. It also offers molecular diagnostics platforms comprising of LIAISON NES, a new molecular platform to address the growing diagnostic decentralization trend; the ARIES and ARIES M1 systems; LIAISON MDX, a thermocycler with two consumable disc options; LIAISON MDX Plus; MAGPIX System; Luminex 100/200 System; VERIGENE System; and the LIAISON PLEX System. It has partnership agreements with QIAGEN for diagnostic solution for Latent Tuberculosis detection; TTP for the development of molecular Point-of-Care solution; and MeMed for the launch of a test differentiating between viral and bacterial infections. The company was founded in 1968 and is headquartered in Saluggia, Italy.

Kimberly-Clark de México, S. A. B. de C. V. OTCMKTS:KCDMY

$9.20 -0.10 (-1.08%)

As of 03:58 PM Eastern

Kimberly-Clark de México, S. A. B. de C. V., together with its subsidiaries, manufactures, distributes, and markets disposable products in Mexico. The company offers baby diapers, training pants, swim pants, wet wipes, shampoos, creams, bar soaps, and feeding products. It also provides toilet papers, napkins, facial tissues, paper towels, feminine pads, panty liners, tampons, intimate wipes, and menstrual cups. In addition, the company offers pets shampoos, sprays, repellents, and cleaners. Further, it provides liquid hand soap, foaming liquid soap, and liquid body wash; and underwear, protectors, feminine pads, pre-folded products for adults. Additionally, the company offers anti-bacterial gels; disinfectant sprays; face masks; dispensers; hand towels; and industrial cleaning cloths. The company offers its products primarily under the Huggies, KleenBebe, Kleenex, Evenflo, Pétalo, Suavel, Cottonelle, Depend, Kotex, Pull-Ups, GoodNites, Vogue, Delsey, Diapro, LYS, Fancy, Kimberly-Clark, and Escudo brands. The company exports its products. Kimberly-Clark de México, S. A. B. de C. V. was founded in 1925 and is based in Mexico City, Mexico.

Pharma Mar OTCMKTS:PHMMF

$80.91 0.00 (0.00%)

As of 05/14/2025

Pharma Mar, S.A., a biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Italy, Germany, Ireland, France, rest of the European Union, the United States, and internationally. The company operates through Oncology and RNA Interference segments. It develops and commercializes Yondelis for the treatment of soft tissue sarcoma and for ovarian cancer; Aplidin for treating R/R multiple myeloma; and Zepzelca to treat patients with small cell lung cancer. The company develops Ecubectedin (PM14), which is in phase II clinical trials for the treatment of solid tumors, as well as in Phase I clinical trials for the treatment of soft tissue sarcoma and prostate cancer; PM534 that is Phase I clinical trials for treating solid tumors; PM54, which is in Phase I clinical trials for the treatment of solid tumors; SYL1801 that is in phase II clinical trials for treating macular degeneration; SYL116011, which is in preclinical studies for the treatment of ocular allergies; and SYL A and B that is in investigational studies to treat retinitis pigmentosa. In addition, it engages in the research, development, production, and sale of products with therapeutic activity based on reducing or silencing gene expression. Pharma Mar, S.A. was incorporated in 1986 and is based in Madrid, Spain.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time